In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke with Andrew Menzies-Gow, MBBS, PhD, Vice President Respiratory & Immunology, Global Biopharmaceuticals Medical, AstraZeneca, about innovations in respiratory and immunology drug development.
Dr. Menzies-Gow is an expert in respiratory biologics and severe asthma research with a prolific career in respiratory medicine, combining his background as a practicing clinician with strategic leadership to advance innovative therapies that address some of the greatest unmet needs in the field.
Under his leadership at AstraZeneca, the company has delivered groundbreaking studies that have shaped clinical guidelines and improved standards of care globally.
Dr. Menzies-Gow has a medical degree from St George’s Hospital Medical School in London and a PhD in eosinophil biology from the National Heart and Lung Institute, Imperial College. He has served as Chair of the NICE guideline development group for Asthma: Diagnosis and Monitoring, and as National Clinical Director for Respiratory Disease for NHS England.
Tune in to hear about AstraZeneca’s vision in the respiratory and immunology space, the innovations shaping the future of care and how global strategies are translating into real-world impact for patients.
The weekly podcast is available for streaming every Wednesday on Spotify, Apple Music and wherever you stream your podcasts.
Subscribe to the Xtalks Life Science Podcast to never miss a new episode.
Join or login to leave a comment
JOIN LOGIN